AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32727162 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g/day Fish Oil (FO)
Number of subjects: 32
Study 32727162 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 32
Study 34165818 — intervention group
Group type: EXPERIMENTAL
Intervention: FESCE-based early-mobility program
Number of subjects: 150
Study 34165818 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 150
Study 34165818 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic euglycemic clamps
Number of subjects: 150
Study 35130935 — intervention group
Group type: EXPERIMENTAL
Intervention: TtLIVE intervention (multi-component virtual care solution including virtual home visits, customizable care plans, clinical workflows, digitally secure communication, resource library)
Number of subjects: 440
Study 35130935 — intervention group
Group type: EXPERIMENTAL
Intervention: TtLIVE intervention
Number of subjects: 440
Study 35130935 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 440
Study 33744617 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced diet + 2,000 units of phytase (FYT)/kg
Number of subjects: 320
Study 33744617 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced diet + 4,000 FYT/kg
Number of subjects: 320
Study 33744617 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced diet + 2,000 FYT/kg
Number of subjects: 320
Study 33744617 — intervention group
Group type: COMPARATOR
Intervention: Basal diet without phytase
Number of subjects: 320
Study 33744617 — intervention group
Group type: COMPARATOR
Intervention: Reduced diet without phytase
Number of subjects: 320
Study 32147390 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 × 10^6 DSC cells
Number of subjects: 65
Study 32147390 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 × 10^6 DSC cells
Number of subjects: 65
Study 32147390 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 × 10^5 DSC cells
Number of subjects: 65
Study 32147390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 35983522 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) group
Number of subjects: 120
Study 35983522 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 35983522 — intervention group
Group type: EXPERIMENTAL
Intervention: CNN group
Number of subjects: 120
Study 34506816 — intervention group
Group type: EXPERIMENTAL
Intervention: Health warnings (none, Canadian, or US warning)
Number of subjects: 45378
Study 34506816 — intervention group
Group type: EXPERIMENTAL
Intervention: Full branding
Number of subjects: 45378
Study 34506816 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain packaging
Number of subjects: 45378
Study 34506816 — intervention group
Group type: EXPERIMENTAL
Intervention: White background with no or limited branding
Number of subjects: 45378
Study 34506816 — intervention group
Group type: EXPERIMENTAL
Intervention: Canadian health warnings
Number of subjects: 45378
Study 34506816 — intervention group
Group type: EXPERIMENTAL
Intervention: US health warnings
Number of subjects: 45378
Study 34506816 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain packages
Number of subjects: 45378
Study 32374229 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-open repair (Group A)
Number of subjects: 80
Study 32374229 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous stabilization (Group B)
Number of subjects: 80
Study 34049911 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment plus calcium dobesilate (CaD) 500 mg three times per day for 12 months
Number of subjects: 1272
Study 34049911 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 1272
Study 36368947 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention including group sports activities, active guidance meetings, and a serious game to set physical activity goals.
Number of subjects: 100
Study 36368947 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 100
Study 33742792 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch (TT) as a complementary therapy
Number of subjects: 1302
Study 33742792 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic touch (TT)
Number of subjects: 1302
Study 32192537 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (walking and lower limb strength training, 12 weeks low-intensity and 12 weeks high-intensity, 3 times/week)
Number of subjects: 91
Study 32192537 — intervention group
Group type: COMPARATOR
Intervention: Control group (attention-matched, flexibility exercises and recreational activities)
Number of subjects: 91
Study 35499504 — intervention group
Group type: EXPERIMENTAL
Intervention: JPFT in the morning (8:00 a.m)
Number of subjects: 12
Study 35499504 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric chin-up test in the afternoon (5:00 p.m)
Number of subjects: 12
Study 35499504 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic chin-up test in the afternoon (5:00 p.m)
Number of subjects: 12
Study 35499504 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic test in the afternoon (5:00 p.m)
Number of subjects: 12
Study 35499504 — intervention group
Group type: EXPERIMENTAL
Intervention: TQR, well-being indices, and POMS
Number of subjects: 12
Study 34897271 — intervention group
Group type: EXPERIMENTAL
Intervention: GH&W + face-to-face group activities (level 2)
Number of subjects: 335
Study 34897271 — intervention group
Group type: EXPERIMENTAL
Intervention: GH&W + individual support in medical checking (level 3)
Number of subjects: 335
Study 34897271 — intervention group
Group type: COMPARATOR
Intervention: Only GH&W (level 1)
Number of subjects: 335
Study 35316556 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (probably in the subacromial bursa)
Number of subjects: 114
Study 35316556 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (definitely in the subacromial bursa)
Number of subjects: 114
Study 35316556 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (definitely/probably not in the subacromial bursa)
Number of subjects: 114
Study 32357899 — intervention group
Group type: EXPERIMENTAL
Intervention: Shengjiang Xiexin decoction (SXD)
Number of subjects: 100
Study 32357899 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33164608 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiar audiobook narrator (Voice 1)
Number of subjects: 30
Study 33164608 — intervention group
Group type: COMPARATOR
Intervention: Unfamiliar audiobook narrator (Voice 2)
Number of subjects: 30
Study 33158001 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling video intervention group (n=10)
Number of subjects: 32
Study 33158001 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo video group (n=11)
Number of subjects: 32
Study 33158001 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=11)
Number of subjects: 32
Study 33158001 — intervention group
Group type: EXPERIMENTAL
Intervention: KOOS subscale scores
Number of subjects: 32
Study 35038136 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation of intersphincteric fistula tract (LIFT)
Number of subjects: 66
Study 35038136 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Parks technique
Number of subjects: 66
Study 35038136 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage seton
Number of subjects: 66
Study 35038136 — intervention group
Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 66
Study 33616605 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric-onset multiple sclerosis (PoMS)
Number of subjects: 485
Study 33616605 — intervention group
Group type: COMPARATOR
Intervention: Matched reference cohort without multiple sclerosis (MS)
Number of subjects: 485
Study 32085537 — intervention group
Group type: EXPERIMENTAL
Intervention: ONS + DA
Number of subjects: 308
Study 32085537 — intervention group
Group type: COMPARATOR
Intervention: DA
Number of subjects: 308
Study 35674591 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous insulin infusion
Number of subjects: 42
Study 35674591 — intervention group
Group type: COMPARATOR
Intervention: Bolus insulin
Number of subjects: 42
Study 32674204 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS)
Number of subjects: 45
Study 32674204 — intervention group
Group type: COMPARATOR
Intervention: Chest X-ray (CXR)
Number of subjects: 45
Study 36256987 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-psychological intervention based on general withdrawal intervention
Number of subjects: 100
Study 36256987 — intervention group
Group type: COMPARATOR
Intervention: General withdrawal intervention (Control)
Number of subjects: 100
Study 33771496 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-hour single-balloon catheter placement with oxytocin
Number of subjects: 178
Study 33771496 — intervention group
Group type: COMPARATOR
Intervention: 12-hour single-balloon catheter placement with oxytocin
Number of subjects: 178
Study 35910931 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally specific sexual and reproductive health curriculum in school
Number of subjects: 0
Study 35910931 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental education to improve parent-child communication about SRH and healthy relationships
Number of subjects: 0
Study 35910931 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural mentorship
Number of subjects: 0
Study 35910931 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement of delivery of SRH services from reservation healthcare agencies
Number of subjects: 0
Study 32864805 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-agent concurrent chemoradiotherapy using S-1
Number of subjects: 105
Study 32864805 — intervention group
Group type: COMPARATOR
Intervention: Double-agent concurrent chemoradiotherapy using S-1 and cisplatin
Number of subjects: 105
Study 35513772 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-severity social exclusion condition
Number of subjects: 372
Study 35513772 — intervention group
Group type: COMPARATOR
Intervention: High-severity social exclusion condition
Number of subjects: 372
Study 33166437 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 10
Study 33166437 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 10
Study 35279025 — intervention group
Group type: EXPERIMENTAL
Intervention: BOOST program (physical and psychological group intervention)
Number of subjects: 438
Study 35279025 — intervention group
Group type: COMPARATOR
Intervention: Best practice advice (BPA)
Number of subjects: 438
Study 34312902 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal design with unequal allocation of clusters and unequal cluster size
Number of subjects: 0
Study 34312902 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal design under constraints on the number of clusters or cluster size
Number of subjects: 0
Study 35080029 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual physiotherapy care interventions (including task specific training delivered at weekly intensity for 4-6 weeks)
Number of subjects: 12
Study 35080029 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring of children with Gross Motor Function Classification System level III on long-term pathways
Number of subjects: 12
Study 33940892 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep embedded clustering (DEC)
Number of subjects: 0
Study 33940892 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaussian mixture models (GMM)
Number of subjects: 0
Study 33940892 — intervention group
Group type: COMPARATOR
Intervention: Conventional clustering
Number of subjects: 0
Study 36001335 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 1660
Study 36001335 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1660
Study 33707161 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional neural networks (CNNs) using chest radiography
Number of subjects: 239
Study 32840653 — intervention group
Group type: EXPERIMENTAL
Intervention: 13C‐TCA and 13C‐TCG in urine
Number of subjects: 0
Study 32840653 — intervention group
Group type: COMPARATOR
Intervention: Plasma concentrations
Number of subjects: 0
Study 32840653 — intervention group
Group type: COMPARATOR
Intervention: Unlabeled biomarker concentrations
Number of subjects: 0
Study 32840653 — intervention group
Group type: COMPARATOR
Intervention: MTCA
Number of subjects: 0
Study 35305231 — intervention group
Group type: EXPERIMENTAL
Intervention: WISE intervention (awareness-raising for staff, peer support service, MHFA training for teachers)
Number of subjects: 25
Study 35305231 — intervention group
Group type: EXPERIMENTAL
Intervention: WISE intervention components
Number of subjects: 25
Study 35305231 — intervention group
Group type: EXPERIMENTAL
Intervention: WISE intervention
Number of subjects: 25
Study 32341291 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 63
Study 32341291 — intervention group
Group type: COMPARATOR
Intervention: Rest intervention
Number of subjects: 63
Study 32341291 — intervention group
Group type: EXPERIMENTAL
Intervention: K-D test reliability
Number of subjects: 63
Study 32341291 — intervention group
Group type: EXPERIMENTAL
Intervention: False-positive rate
Number of subjects: 63
Study 36036977 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-thickness skin microbiopsies harvested at diameters of 200, 400, 500, 600, 800 μm, 1, and 2 mm
Number of subjects: 8
Study 33130147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 476
Study 32130090 — intervention group
Group type: EXPERIMENTAL
Intervention: NO3‐rich beetroot juice (BR; ∼ 9.2 mmol NO3‐)
Number of subjects: 11
Study 32130090 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11
Study 32629737 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) decoction for 4 weeks
Number of subjects: 150
Study 32629737 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib (specific daily dose)
Number of subjects: 150
Study 32629737 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM decoction
Number of subjects: 150
Study 32629737 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 150
Study 35039203 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field therapy (PEMF) applied via a removable appliance worn for 8-10 hours during canine retraction.
Number of subjects: 19
Study 35039203 — intervention group
Group type: COMPARATOR
Intervention: Control side with no PEMF exposure (obstructed by foil).
Number of subjects: 19
Study 33151266 — intervention group
Group type: EXPERIMENTAL
Intervention: CTC-driven treatment choice (chemotherapy if ≥5 CTCs/7.5 mL; endocrine therapy if <5 CTCs/7.5 mL)
Number of subjects: 755
Study 33151266 — intervention group
Group type: COMPARATOR
Intervention: Clinician-driven treatment choice (control arm)
Number of subjects: 755
Study 33151266 — intervention group
Group type: EXPERIMENTAL
Intervention: CTC-driven treatment choice
Number of subjects: 755
Study 33151266 — intervention group
Group type: COMPARATOR
Intervention: Clinician-driven treatment choice
Number of subjects: 755
Study 32895015 — intervention group
Group type: EXPERIMENTAL
Intervention: Long sleep (≤9 hours per day)
Number of subjects: 79881
Study 32895015 — intervention group
Group type: EXPERIMENTAL
Intervention: Short sleep (<7 hours per day)
Number of subjects: 79881
Study 32895015 — intervention group
Group type: COMPARATOR
Intervention: Mendelian randomization analysis
Number of subjects: 79881
Study 34788571 — intervention group
Group type: EXPERIMENTAL
Intervention: Golodirsen 30 mg/kg
Number of subjects: 23
Study 34788571 — intervention group
Group type: EXPERIMENTAL
Intervention: Golodirsen
Number of subjects: 23
Study 34788571 — intervention group
Group type: COMPARATOR
Intervention: External controls
Number of subjects: 23
Study 32621905 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing-enhanced integrated behavior therapy
Number of subjects: 0
Study 32621905 — intervention group
Group type: COMPARATOR
Intervention: Integrated behavior therapy (video-based behavioral weight loss program and problem-solving therapy for depression)
Number of subjects: 0
Study 34204400 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV)
Number of subjects: 64
Study 34204400 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle ergometer training
Number of subjects: 64
Study 34204400 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 64
Study 32084567 — intervention group
Group type: COMPARATOR
Intervention: Standard defibrillation
Number of subjects: 152
Study 32084567 — intervention group
Group type: EXPERIMENTAL
Intervention: Vector change defibrillation (VC)
Number of subjects: 152
Study 32084567 — intervention group
Group type: EXPERIMENTAL
Intervention: Double sequential external defibrillation (DSED)
Number of subjects: 152
Study 35610743 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative Transfusion Trigger Score (POTTS) group
Number of subjects: 864
Study 35610743 — intervention group
Group type: COMPARATOR
Intervention: Control group (based on 2012 AABB guideline)
Number of subjects: 864
Study 35610743 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 864
Study 33839429 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compression on the right breast
Number of subjects: 200
Study 33839429 — intervention group
Group type: COMPARATOR
Intervention: Standard mammographic procedure (control group)
Number of subjects: 200
Study 34863776 — intervention group
Group type: EXPERIMENTAL
Intervention: RLRL treatment plus single-vision spectacle (SVS)
Number of subjects: 264
Study 34863776 — intervention group
Group type: COMPARATOR
Intervention: SVS
Number of subjects: 264
Study 34863776 — intervention group
Group type: EXPERIMENTAL
Intervention: RLRL treatment
Number of subjects: 264
Study 32820334 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 1205
Study 36096283 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalox‐Comm training module
Number of subjects: 60
Study 36096283 — intervention group
Group type: COMPARATOR
Intervention: Basic online naloxone training module (control group)
Number of subjects: 60
Study 33516047 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation intervention (n=72)
Number of subjects: 144
Study 33516047 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (n=72)
Number of subjects: 144
Study 32868821 — intervention group
Group type: EXPERIMENTAL
Intervention: Rainfall
Number of subjects: 0
Study 32868821 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature
Number of subjects: 0
Study 32868821 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol
Number of subjects: 0
Study 32868821 — intervention group
Group type: EXPERIMENTAL
Intervention: Precipitation
Number of subjects: 0
Study 33446635 — intervention group
Group type: EXPERIMENTAL
Intervention: 14:10 Time Restricted Eating (TRE)
Number of subjects: 78
Study 33446635 — intervention group
Group type: COMPARATOR
Intervention: 12:12 Time Restricted Eating (TRE) (active comparator)
Number of subjects: 78
Study 32886102 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel surgery (modified uvulopalatopharyngoplasty and minimally invasive tongue volume reduction; n=51)
Number of subjects: 102
Study 32886102 — intervention group
Group type: COMPARATOR
Intervention: Ongoing medical management (eg, advice on sleep positioning, weight loss; n=51)
Number of subjects: 102
Study 32886102 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel surgery
Number of subjects: 102
Study 32886102 — intervention group
Group type: COMPARATOR
Intervention: Ongoing medical management
Number of subjects: 102
Study 35690262 — intervention group
Group type: EXPERIMENTAL
Intervention: SHARING Choices intervention
Number of subjects: 55
Study 35690262 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 55
Study 34642244 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuing β‐lactam treatment after 3 days
Number of subjects: 0
Study 34642244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32202637 — intervention group
Group type: EXPERIMENTAL
Intervention: Acalabrutinib 100 mg twice daily (BID)
Number of subjects: 48
Study 32202637 — intervention group
Group type: EXPERIMENTAL
Intervention: Acalabrutinib 200 mg once daily (QD)
Number of subjects: 48
Study 35719236 — intervention group
Group type: EXPERIMENTAL
Intervention: Sand-based PJT combined with endurance running on outdoor surface (OT)
Number of subjects: 75
Study 35719236 — intervention group
Group type: EXPERIMENTAL
Intervention: Sand-based PJT combined with endurance running on treadmill surface (TT)
Number of subjects: 75
Study 35719236 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 75
Study 34023797 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-39393406 (n=35)
Number of subjects: 71
Study 34023797 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=36)
Number of subjects: 71
Study 35764522 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding combined with quadruple therapy
Number of subjects: 139
Study 35764522 — intervention group
Group type: COMPARATOR
Intervention: Oral Weifuchun Tablets with quadruple therapy
Number of subjects: 139
Study 32388694 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC) intervention
Number of subjects: 186
Study 32388694 — intervention group
Group type: COMPARATOR
Intervention: Control participants received home-based EHS plus 10 weekly books
Number of subjects: 186
Study 34563096 — intervention group
Group type: EXPERIMENTAL
Intervention: NUDT15 genotype-based dose optimisation (50% dose reduction for CT genotype, alternative drugs for TT genotype)
Number of subjects: 118
Study 34563096 — intervention group
Group type: EXPERIMENTAL
Intervention: NUDT15 genotype-based dose optimisation (50% dose reduction for CT genotype)
Number of subjects: 118
Study 34563096 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard dose for CC genotype)
Number of subjects: 118
Study 36443615 — intervention group
Group type: EXPERIMENTAL
Intervention: SEIP IMN technique
Number of subjects: 88
Study 36443615 — intervention group
Group type: COMPARATOR
Intervention: HFIP IMN technique
Number of subjects: 88
Study 34530254 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab-abbs
Number of subjects: 201